Accuray | ARAY - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
Abbott USD 11.66B 1.2B 2026-09
Accuray USD 37.18M 567K 2024-12
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 143.94M 3.22M 2026-06
Boston Scientific USD 4.13B 72M 2026-09
Edwards Lifesciences USD 1.22B 87.6M 2026-06
Inogen USD 49.14M 665K 2024-09
Mesa Laboratories USD 33.98M 2.03M 2024-12
Orthofix International USD 213.79M 12.36M 2025-12
Tandem Diabetes Care USD 268.35M 3.7M 2026-06
Trinity Biotech USD 12.38M 2.44M 2025-12